IRIS
CONTI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.150
AS - Asia 9.256
EU - Europa 7.006
SA - Sud America 1.571
AF - Africa 530
Continente sconosciuto - Info sul continente non disponibili 221
OC - Oceania 8
Totale 29.742
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.777
SG - Singapore 3.475
CN - Cina 2.602
VN - Vietnam 1.563
BR - Brasile 1.237
DE - Germania 1.087
IE - Irlanda 1.082
IT - Italia 889
FI - Finlandia 874
UA - Ucraina 863
SE - Svezia 833
HK - Hong Kong 605
ZA - Sudafrica 382
FR - Francia 335
NL - Olanda 316
CA - Canada 259
TR - Turchia 213
BD - Bangladesh 187
GB - Regno Unito 175
AT - Austria 173
RU - Federazione Russa 137
AR - Argentina 129
IN - India 122
JP - Giappone 73
EC - Ecuador 66
MX - Messico 60
IQ - Iraq 54
ES - Italia 51
ID - Indonesia 47
BE - Belgio 45
KR - Corea 35
CO - Colombia 34
PK - Pakistan 34
PL - Polonia 34
PH - Filippine 33
MA - Marocco 32
VE - Venezuela 31
TW - Taiwan 27
KE - Kenya 26
PY - Paraguay 26
UZ - Uzbekistan 26
CZ - Repubblica Ceca 23
EG - Egitto 23
TH - Thailandia 22
LT - Lituania 19
SA - Arabia Saudita 17
IL - Israele 16
UY - Uruguay 15
JO - Giordania 14
NP - Nepal 13
CL - Cile 12
EU - Europa 12
TN - Tunisia 12
AZ - Azerbaigian 11
CI - Costa d'Avorio 11
CR - Costa Rica 11
JM - Giamaica 11
AE - Emirati Arabi Uniti 10
BO - Bolivia 9
PE - Perù 9
BG - Bulgaria 7
CH - Svizzera 7
RO - Romania 7
ET - Etiopia 6
KZ - Kazakistan 6
OM - Oman 6
PS - Palestinian Territory 6
RS - Serbia 6
BH - Bahrain 5
BJ - Benin 5
BY - Bielorussia 5
LB - Libano 5
TT - Trinidad e Tobago 5
AO - Angola 4
AU - Australia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
HN - Honduras 4
MY - Malesia 4
PA - Panama 4
PT - Portogallo 4
TG - Togo 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
CY - Cipro 3
GD - Grenada 3
HU - Ungheria 3
KW - Kuwait 3
LU - Lussemburgo 3
LV - Lettonia 3
NG - Nigeria 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
ZW - Zimbabwe 3
AM - Armenia 2
EE - Estonia 2
GE - Georgia 2
Totale 29.482
Salva come PNG Salva come JPEG
Città #
Singapore 1.548
Ashburn 1.089
Dublin 1.070
Jacksonville 968
San Jose 934
Chandler 885
Beijing 648
Dallas 582
Hong Kong 579
Santa Clara 559
Ho Chi Minh City 503
Dearborn 403
Boardman 362
Johannesburg 357
Hanoi 354
Nanjing 341
Ann Arbor 332
Council Bluffs 321
Bremen 260
Princeton 259
San Mateo 248
Lauterbourg 229
Parma 226
Munich 208
New York 192
Los Angeles 177
Toronto 165
Vienna 163
Helsinki 153
Izmir 149
Wilmington 138
Shanghai 125
Des Moines 119
Shenyang 114
Hefei 112
Moscow 97
São Paulo 96
Kunming 95
Hebei 93
Nanchang 87
Haiphong 75
Buffalo 74
Jinan 69
Da Nang 62
Woodbridge 59
Seattle 58
Milan 57
Marseille 54
Columbus 51
Grafing 51
Turku 51
Guangzhou 49
Changsha 47
Tianjin 46
Düsseldorf 45
Tokyo 44
Brussels 43
Houston 40
Atlanta 39
Fortaleza 39
Rio de Janeiro 36
Jiaxing 35
The Dalles 35
Orem 34
Brooklyn 32
Montreal 31
Frankfurt am Main 29
Hải Dương 29
Biên Hòa 28
Fremont 28
Rome 28
Warsaw 28
Chennai 27
Denver 27
Quito 27
London 25
Seoul 25
Zhengzhou 25
Norwalk 24
Hangzhou 23
Nuremberg 23
Jakarta 22
Tashkent 22
Brasília 21
Curitiba 21
Bắc Ninh 20
Nairobi 20
Phoenix 20
Porto Alegre 20
San Francisco 20
Can Tho 19
Verona 19
Belo Horizonte 18
Istanbul 18
Washington 18
Amsterdam 17
Salvador 17
Baghdad 16
Boston 16
Chicago 16
Totale 17.352
Salva come PNG Salva come JPEG
Nome #
Anti-Herpetic Activity of Killer Peptide (KP): An In Vitro Study 331
A transphyletic anti-infectious control strategy based on the killer phenomenon. 283
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 256
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 256
Production of an engineered killer peptide in Nicotiana benthamiana by using a Potato virus X expression system 230
Antibacterial effects of two synthetic peptides against Enterococcus faecalis biofilms: A preliminary in vitro study 230
Anti-Staphylococcus aureus Activity and Structural Characterization of Rationally Designed Peptides 216
Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins 215
Anti-infective antibody-derived peptides active against endogenous and exogenous fungi 207
In vitro and in vivo anti-Candida activity and structural analysis of killer peptide (KP)-derivatives 203
Activity of two antimicrobial peptides against Enterococcus faecalis in a model of biofilm-mediated endodontic infection 201
A synthetic peptide as a novel anticryptococcal agent 195
Antibodies as a source of anti-infective peptides: an update 195
Candidacidal activity of a novel killer toxin from Wickerhamomyces anomalus against fluconazole-susceptible and -resistant strains 194
A peptide found in human serum, derived from the c-terminus of albumin, shows antifungal activity in vitro and in vivo 193
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 193
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 185
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 185
Activity of Synthetic Peptide KP and Its Derivatives against Biofilm-Producing Escherichia coli Strains Resistant to Cephalosporins 181
Antimicrobial peptide L18R displays a modulating action against inter-kingdom biofilms in the Lubbock chronic wound biofilm model 180
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 179
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 176
Metabolic profiling of Candida albicans 176
Antifungal peptides within the antibodies 172
Antifungal activity of the C-terminal peptide from human serum albumin 169
Antimicrobial effect on candida albicans biofilm bapplication of different wavelengths and dyes and the synthetic killer decapeptide KP 168
L’antibiogramma per i miceti 167
Fungicidal activity of peptides encoded by immunoglobulin genes 167
Peptides of the Constant Region of Antibodies Display Fungicidal Activity 167
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies 166
Effect of different wavelengths and dyes on Candida albicans: In vivo study using Galleria mellonella as an experimental model 165
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 164
Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway. 160
Novel Arginine- and Proline-Rich Candidacidal Peptides Obtained through a Bioinformatic Approach 159
Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity 159
Metabolic Plasticity of Candida albicans in Response to Different Environmental Conditions 157
Anaerobic yeast killer system. 155
Antibody peptide based antifungal immunotherapy 155
Antimicrobial activity of poultry bone and meat trimmings hydrolyzates in low-sodium turkey food 155
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 155
Peptides from the inside of the antibodies are active against infectious agents and tumours 155
Valutazione del sistema Bactec Mycobacterial Growth Indicator Tube (MGIT) 960 per il rilevamento di micobatteri dai materiali patologici in comparazione ai metodi radiometrico e tradizionale 154
ANTIMICROBIAL EFFECT ON CANDIDA ALBICANS BIOFILMS WITH DIFFERENT WAVELENGTHS AND DYES WITH SYNTHETIC KILLER DECAPEPTIDE 154
Natural and synthetic peptides with antifungal activity 153
Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. 152
Anticorpi immagini interne di tossine killer 151
Antibody-mediated protective immunity in fungal infections 150
A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities 150
Anticorpi antibiotici antiidiotipo immagini interne di tossine killer. 150
Antimicrobial photodynamic therapy protocols on streptococcus mutans with different combinations of wavelengths and photosensitizing dyes 149
ANTIMICROBIAL EFFECT ON CANDIDA ALBICANS BY DIFFERENT COUPLING OF WAVELENGTHS AND COLORS IN PHOTODYNAMIC PROTOCOLS: IN VITRO AND IN VIVO STUDY 148
"Antibiobodies": yeast killer toxin-like anti-idiotypic antibodies 145
Antibiobodies: antibiotic-like antiidiotypic antibodies. 145
Antibiocorpi: anticorpi antiidiotipo ad attività antibiotica e profilattica. 144
Antimicrobial peptides with antiprotozoal activity: Current state and future perspectives 143
Antireceptor yeast killer toxin-like antibiobodies 142
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 142
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 142
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk 141
Significato diagnostico delle IgA (secretorie) adese a miceti lievitiformi nel corso delle infezioni orali di pazienti a rischio. 141
Mode of action of a killer peptide against Toxoplasma gondii 139
Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade 137
Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide 137
Detection of Mycobacterium bovis in bovine tissue samples by the Abbott LCx Mycobacterium tuberculosis assay and comparison with culture methods 136
Antibiobodies: antibiotic internal image antibodies 136
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 136
A Multicenter Comparative Evaluation of Six Commercial Systems and the National Committee for Clinical Laboratory Standards M27-A Broth Microdilution Method for Fluconazole Susceptibility Testing of Candida Species 136
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs 135
In vitro activity of killer peptide against Toxoplasma gondii tachyzoites 134
Guideline for the analysis of the microbial communities of the human upper airways 133
Metabolic profile of Candida albicans 133
Attività in vitro e in vivo nei confronti di Candida albicans di peptidi sintetici progettati in silico 132
Wickerhamomyces yeast killer toxins’ medical applications 132
In silico predicted antifungal peptides: In vitro and in vivo anti-candida activity 132
Allergic bronchopulmonary aspergillosis: An important cause of asthma which is sometimes ignored 130
Antibiotic antibodies 127
In vitro and in vivo anticandidal activity of killer peptide derivatives 126
Antiviral Activity of Synthetic Peptides Derived from Physiological Proteins 125
The Variability of the Salivary Antimicrobial Peptide Profile: Impact of Lifestyle 124
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis 124
Innate antimicrobial and antiviral activities of antibody peptides 124
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation 124
Restriction of Influenza virus multiplication induced by PK peptide treatment 122
A Wickerhamomyces anomalus killer strain in the malaria vector Anopheles stephensi 122
Development of a novel paratransgenic symbiotic-based control strategy for vector-borne infectious diseases 121
Caratterizzazione di mannoproteine da stress di Candida albicans reattive con IgA secretorie 120
Marcatori epidemiologici. 120
In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus. 119
Inhibition performed by a synthetic microbicidal peptide on the replication of Influenza virus. Abstract 21.009 115
Antibodies as Crypts of Antiinfective and Antitumor Peptides 114
Any antibody fragment might exert antifungal activity 113
Idiotypic antifungal vaccination: Immunoprotection by antiidiotypic antibiotic antibodies 113
Candidacidal properties of peptides encoded by immunoglobulin genes 112
Human natural yeast killer toxin-like antibodies 111
Yeast killer toxins and dimorphism. 111
Biotyping of pathogenic fungi by the killer system and with monoclonal antibodies. 111
Relazione struttura-funzione di un peptide fungicida derivato dalla regione costante di immunoglobuline G umane 111
Therapeutic potential of yeast killer toxin-like antibodies and mimotopes 110
Immagine interna del fenomeno killer dei lieviti 109
Reversible self-assembly: A key feature for a new class of autodelivering therapeutic peptides 108
Totale 15.525
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.627
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.627
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.275 0 6 24 59 58 68 169 221 51 128 64 427
2022/20234.045 504 352 216 259 539 456 35 235 1.311 12 92 34
2023/20241.363 79 147 48 55 132 381 59 77 25 90 113 157
2024/20254.772 52 303 317 334 357 517 149 197 788 485 382 891
2025/202610.710 840 1.049 1.356 1.231 1.469 600 1.218 410 1.357 691 303 186
2026/2027819 654 165 0 0 0 0 0 0 0 0 0 0
Totale 29.742